Tradr launches 2X leveraged ETFs for Datadog, Astera Labs.

martes, 12 de agosto de 2025, 6:50 am ET1 min de lectura
ALAB--
CBOE--
DDOG--

• Tradr ETFs launches two 2X long single-stock funds • Funds track Datadog and Astera Labs, AI-enabling infrastructure names • Both funds aim to deliver twice the daily performance of the underlying stock • Listed on Cboe, these are first-to-market strategies for sophisticated investors and professional traders

Tradr ETFs has announced the launch of two new 2X long single-stock ETFs, marking a significant expansion of their leveraged ETF lineup. The funds, Tradr 2X Long DDOG Daily ETF (Cboe: DOGD) and Tradr 2X Long ALAB Daily ETF (Cboe: LABX), are set to debut on Tuesday, August 12, 2025 [1].

The new ETFs will provide investors with twice the daily performance of their respective underlying stocks: Datadog Inc. (Nasdaq: DDOG) and Astera Labs Inc. (Nasdaq: ALAB). Both companies are key players in the AI-enabling infrastructure sector, known for their innovative growth narratives [1].

Tradr ETFs, designed for sophisticated investors and professional traders, currently offers 20 leveraged ETFs. The addition of these two funds will bring the total to 21, further expanding their product suite. The company aims to cater to investors seeking high conviction investment views through leveraged and inverse ETFs [1].

Astera Labs, which went public in March 2024, has seen substantial revenue growth over the past several years, while Datadog, recently added to the S&P 500 Index, has been a remarkable growth story since its inception just under six years ago [1].

The new funds will be listed on Cboe and are intended to be used as short-term trading vehicles. Investors should be aware of the significant risks associated with leveraged ETFs, including the potential for increased volatility and the possibility of total loss of investment [1].

References:
[1] https://www.prnewswire.com/news-releases/tradr-readies-leveraged-single-stock-etfs-on-alab-and-ddog-302525223.html

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios